CR vs DCI

CR demonstrates stable financial health with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a Current Ratio of 5.53. However, the stock is trading at a severe premium, with the current price of $180.08 vastly exceeding both the Graham Number ($67.44) and the growth-based Intrinsic Value ($41.25). While the company maintains a stellar track record of earnings beats over 25 quarters, the technical trend is currently bearish (0/100) and YoY earnings growth is nearly stagnant at 0.20%. The disconnect between fundamental value and market price suggests a high-quality business that is currently overvalued.

DCI presents a stable financial health profile with a Piotroski F-Score of 4/9 and low leverage, but it is severely overvalued. The current price of $88.96 trades at a massive premium to its Graham Number ($31.29) and Intrinsic Value ($22.40). With stagnant revenue growth (3%) and negative earnings growth (-1.3%), the current P/E of 27.80 is fundamentally unsupported. Bearish insider selling and a 0/100 technical trend further suggest a lack of immediate catalyst for growth.